According to Quest Diagnostics 's latest financial reports the company's current earnings (TTM) are $1.13 B. In 2022 the company made an earning of $1.23 B a decrease over its 2021 earnings that were of $2.59 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | $1.13 B | -8.5% |
2022 | $1.23 B | -52.48% |
2021 | $2.59 B | 37.95% |
2020 | $1.88 B | 75.09% |
2019 | $1.07 B | 16.2% |
2018 | $0.92 B | -10.1% |
2017 | $1.03 B | -5.16% |
2016 | $1.08 B | -1.54% |
2015 | $1.10 B | 31% |
2014 | $0.84 B | -37.52% |
2013 | $1.34 B | 26.93% |
2012 | $1.06 B | 24.01% |
2011 | $0.85 B | -27.7% |
2010 | $1.18 B | -3.55% |
2009 | $1.22 B | 19.59% |
2008 | $1.02 B | 12.54% |
2007 | $0.91 B | -11.7% |
2006 | $1.03 B | 13.49% |
2005 | $0.91 B | 9.02% |
2004 | $0.83 B | 13.19% |
2003 | $0.73 B | 36.03% |
2002 | $0.54 B | 63.07% |
2001 | $0.33 B |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
LabCorp LH | $0.77 B | -31.50% | ๐บ๐ธ USA |
Translate Bio
TBIO.defunct | $41.68 M | -96.31% | ๐บ๐ธ USA |
Psychemedics PMD | -$3.44 M | -100.30% | ๐บ๐ธ USA |
NeoGenomics
NEO | -$90.19 M | -107.98% | ๐บ๐ธ USA |
Qiagen QGEN | $0.48 B | -57.24% | ๐ณ๐ฑ Netherlands |
Enzo Biochem ENZ | -$9.61 M | -100.85% | ๐บ๐ธ USA |